Matrix metalloproteinase-9 (MMP-9) degrades tight junction proteins (claudin-5, occludin, ZO-1) and extracellular matrix components of the neurovascular unit. The balance between MMP-9 and its inhibitor TIMP-1 determines the extent of BBB paracellular leakage. An elevated MMP-9/TIMP-1 ratio in CSF may serve as an early biomarker for neurodegeneration, but significant confounds from systemic inflammation and the invasive nature of CSF collection limit clinical utility. Historical failure of MMP-9 inhibitors in oncology and cardiovascular disease also weighs against therapeutic development.
Curated pathway from expert analysis
flowchart TD
A["Elevated MMP-9 Activity"] -->|"Degrades"| B["Tight Junction Protein Degradation"]
B -->|"Claudin-5, occludin, ZO-1"| C["BBB Paracellular Leakage"]
C -->|"Neurovascular unit disruption"| D["Neurodegeneration"]
A -->|"Reduced inhibition"| E["Decreased TIMP-1 Levels"]
A -->|"Imbalance"| F{"MMP-9/TIMP-1 Ratio Elevation"}
F -->|"Early biomarker signal"| G["CSF Biomarker Potential"]
F -->|"Correlates with severity"| D
H["Systemic Inflammation"] -->|"Confound factor"| F
H -->|"Alternative source"| A
I["Invasive CSF Collection"] -.->|"Clinical utility limitation"| G
J["Historical MMP-9 Inhibitor Failure"] -.->|"Therapeutic development barrier"| K["Therapeutic Development Challenges"]
A -.->|"Target engaged"| JNo linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MMP9, TIMP1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If MMP-9/TIMP-1 ratio in CSF identifies preclinical tight junction degradation before BBB leakage appears in blood, then CSF MMP-9/TIMP-1 ratio will be elevated in CN subjects who later convert to MCI | In CN subjects followed for 3 years (n≥150), those with baseline CSF MMP-9/TIMP-1 ratio in top tertile show 3-4x higher MCI conversion rate (HR>3.5), with conve | — no observation — | pending | 0.77 |